服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-TNFRSF10B/CD262/DR5/TRAILR2 mAbs [Tilogotamab Biosimilar] (MABL-5320) | MABL-5320 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AXL/UFO mAbs [Tilvestamab Biosimilar] (MABL-5321) | MABL-5321 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL13;IL4 mAbs [Tilrekimig1 Biosimilar] (MABL-5322) | MABL-5322 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-PDCD1/CD279/PD1;LAG3/CD223 mAbs [Tebotelimab Biosimilar] (MABL-5294) | MABL-5294 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-CD40;TNFRSF9/CD137/4-1BB mAbs [Tecaginlimab Biosimilar] (MABL-5295) | MABL-5295 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Teclistamab Biosimilar] (MABL-5296) | MABL-5296 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Lambda;Lambda |
| Anti-CLDN18 mAbs [Tecotabart Biosimilar] (MABL-5297) | MABL-5297 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD40LG/CD154 mAbs [Tegoprubart Biosimilar] (MABL-5298) | MABL-5298 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Telazorlimab Biosimilar] (MABL-5299) | MABL-5299 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL4R/CD124 mAbs [Telikibart Biosimilar] (MABL-5300) | MABL-5300 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MET/HGFR mAbs [Telisotuzumab Biosimilar] (MABL-5301) | MABL-5301 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS-associated Retrovirus Envelope Protein mAbs [Temelimab Biosimilar] (MABL-5302) | MABL-5302 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL22RA1 mAbs [Temtokibart Biosimilar] (MABL-5303) | MABL-5303 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TNC mAbs [Tenatumomab Biosimilar] (MABL-5304) | MABL-5304 | ELISA, FACS, Functional assay, in vivo binding | G2b, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Teneliximab Biosimilar] (MABL-5305) | MABL-5305 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Teplizumab Biosimilar] (MABL-5306) | MABL-5306 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Tagitanlimab Biosimilar] (MABL-5278) | MABL-5278 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL3RA/CD123 mAbs [Talacotuzumab Biosimilar] (MABL-5279) | MABL-5279 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IgE mAbs [Talizumab Biosimilar] (MABL-5280) | MABL-5280 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GPRC5D;CD3E mAbs [Talquetamab Biosimilar] (MABL-5281) | MABL-5281 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn